Borealis Biotechnology is a leading provider of Business Development and technology assessment services to the biopharmaceutical industry, offering innovative solutions to a wide range of challenges faced by pharmaceutical companies, biotechnology firms, and vaccine developers worldwide.
With over 15 years of experience, Borealis Biotechnology has established itself as a trusted partner in negotiating license agreements, manufacturing agreements, and partnering agreements, leveraging their unique perspective as both buyers and sellers of technology and services. Their state-of-the-art cost of goods model for biologics and vaccines has been widely tested and proven to be accurate, user-interactive, comprehensive, and easy to use, making them a valuable resource in the biotechnology and biopharmaceutical industry.
Generated from the website